Related by context. All words. (Click for frequent words.) 67 Predictive medicine 66 4SC AG ISIN DE# 64 kidney urologic 64 please visit http:/www.vandapharma.com 64 Nasdaq PGNX today 63 MSCRAMM ® 63 Luveris R Ovidrel R 63 GVAX ® 63 OTCBB NRGX 63 5 lipoxygenase activating 63 improve impulse conduction 62 Through Glycoscience R 62 Telik logo TELINTRA 62 pralatrexate injection folate analogue 62 Prodarsan R 62 inhibit oxidative stress 62 Crofelemer budesonide foam 62 Inc. www.micromet inc.com 62 ThermoDox ® clinical 61 CD# CEA 61 Initiates Phase II 61 NASDAQ ARRY 61 PORxin TM platforms 61 product platforms AZX# 61 Therapeutic Competitors Companies 60 SinuNase ™ 60 memantine HCl 60 GLOBE NEWSWIRE Cytomedix 60 oral dihydropyrimidine dehydrogenase DPD 60 Initiates Enrollment 60 CYT# potent vascular disrupting 60 acetonide FA 60 TRACON Pharmaceuticals 60 visit biotech.com 60 hyaluronidase enzyme 60 programs visit http:/www.bionovo.com 60 orally administered synthetic retinoid 60 developing ACAPODENE 60 Nasdaq ENMD 60 Begins Dosing 60 accumulate preferentially 60 Ovitrelle R Serostim 60 bipolar wafer 60 Initiates Clinical Trial 60 pharmacogenomic translational research 60 Completes Patient Enrollment 60 HuCNS SC ® 60 personalized cellular immunotherapy 60 Protexia ® 60 PRNewswire FirstCall Savient Pharmaceuticals 60 Budesonide foam crofelemer 60 SIX RO ROG 60 Nasdaq OSIP 60 Selective Electrochemical Tumor Ablation 60 Alfacell proprietary ribonuclease 59 Inc. Nasdaq TPTX 59 ospemifene 59 Chrysalin r rusalatide acetate 59 Visit www.BASInc.com 59 MCSP respectively 59 visit www.genmab.com 59 demonstrated antitumor activity 59 TRANSDUR ® 59 active AKT inhibitor 59 Arno Therapeutics 59 Veronate R 59 oral ghrelin agonist 59 drug pipeline TAFA# 59 initiated Phase Ib 59 Antigen Express website 59 rxRNA 59 recombinant PSMA vaccine 59 Curaxin CBLC# 59 trastuzumab DM1 T DM1 59 rusalatide acetate 59 huC# DM4 59 By JAMAAL ABDUL 59 secretory phospholipase A2 59 DNA methyltransferase inhibitors 59 telomerase inhibitor drug 59 PSMA ADC 59 commercializing oxidized glutathione 59 telomerase therapeutic 59 pentadentate logo R 59 IMPDH inhibitor 59 technology visit http:/www.genmab.com 59 VEGFR2 inhibitor 58 oncolytic virus therapies 58 include Altastaph TM 58 non nucleoside inhibitor 58 Solazed TM 58 TSX HYG NASDAQ HYGS 58 ocular formulation 58 INSPIRE Trial Phase III 58 R MSCRAMM 58 thrombin component 58 agonistic human 58 Using Dip Pen 58 diabetes irritable bowel 58 romazarit 58 AQD class 58 developing ostarine selective 58 AcryMed technologies 58 Nasdaq DVAX 58 please visit http:/www.sunesis.com 58 novel peptides 58 OTCBB TDLP 58 HGS ETR1 mapatumumab 58 please visit www.metabolon.com 58 AcryMed Incorporated 58 AAG geldanamycin analog 58 Aeolus Pharmaceuticals Announces 58 sarcoma melanoma 58 Presents Preclinical 58 CDK cyclin dependent 58 novel therapeutic antibodies 58 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 58 molecular chaperone regulation 58 website http:/www.celsion.com 58 sulfonylhydrazine class 58 developing adecatumumab 58 adecatumumab MT# 58 Presents Positive 58 virus HCV protease inhibitor 58 delivers fluocinolone acetonide FA 58 TKB# 58 Pharma Merck Serono 58 MAGE A3 ASCI 58 TM Aganocide 58 anionic backbone 58 affiliate Evogene Ltd. TASE 58 refractory chronic lymphocytic 58 TELINTRA R 58 Cytogen marketed 58 tumors GIST 58 XL# anticancer compounds 57 visit www.targanta.com 57 Phase #b/#a clinical 57 NASDAQ MNKD focuses 57 GVAX R 57 multicenter Phase III 57 non nucleoside HCV 57 Nasdaq IDRA today 57 KNS # 57 FOLOTYN folate analogue 57 Pruvel TM 57 Zalypsis 57 Corporation Nasdaq HYGS 57 oral nucleoside analogue 57 OMNARIS HFA 57 Nasdaq SGMO announced 57 XOMA 3AB 57 lead molecular radiotherapeutic 57 please visit www.advaxis.com 57 investigational oral hepatitis C 57 please visit http:/www.atherogenics.com 57 Proellex TM 57 candidate CRLX# 57 Phase Ib clinical trials 57 PANVAC VF 57 Kosan Biosciences Incorporated 57 Empatic ™ 57 FOLOTYN ® 57 anti CD3 monoclonal 57 Reports Preclinical Data 57 solid tumors ZYBRESTAT 57 Epothilone D 57 PI3K/Akt pathway inhibitor 57 Receives Fast Track 57 HCV NS5B polymerase 57 NASDAQ CGEN announced 57 inflammatory autoimmune diseases 57 Nicotine Conjugate Vaccine 57 Inc. Nasdaq OXGN 57 Tarvacin Anti Cancer 57 world safest multivalent 57 VentiRx Pharmaceuticals 57 vapreotide acetate 57 arsenic trioxide injection 57 refractory gout 57 Nasdaq TGAL leading 57 novel histone deacetylase 57 anti botulism antibody 57 SPL# Gel vaginal microbicide 57 PLX# RG# 57 ATRA IV 57 symbol AVXL 57 initiated Phase 1b 57 Phase 1b clinical trials 57 website www.celsion.com 57 Nventa proprietary CoVal 57 evaluating tivozanib 57 commercialize CorMedix drug 57 Xcytrin R 57 TLR7 agonist 57 targeted radiotherapeutic 56 transthyretin TTR 56 novel antimitotic agent 56 Solazed 56 See BioWorld Today 56 TRIOLEX HE# APOPTONE HE# 56 Provectus Pharmaceuticals specializes 56 human IgG1 monoclonal 56 albiglutide 56 YOUR LOCAL ANIMAL SHELTER 56 PNP inhibitor 56 ENMD # 56 Omacetaxine 56 www.cellgenesys.com 56 apricitabine ATC 56 CCR9 antagonist 56 leading oral taxane 56 Cariprazine 56 INxin TM 56 orally administered inhibitor 56 adhesion molecule EpCAM expressing 56 MT# MEDI 56 ALN HTT 56 Nanobody R 56 MKC# MT 56 INFeD R 56 Sudhir Agrawal D.Phil 56 jjorgensen@eagletribune.com 56 please visit www.tranzyme.com 56 receptor inhibiting monoclonal 56 stage antibody MT# 56 HCV nucleotide polymerase inhibitor 56 coronary stent merged 56 product candidate Lpathomab 56 RenaZorb TM 56 Submits NDA 56 dennisb@theitem.com 56 Kosan dependence 56 GetGoal Phase III 56 SparVax ™ 56 Initiates Clinical 56 IAP inhibitor 56 :# # 56 symbol DFE 56 Merck OSI Pharmaceuticals 56 potently inhibit 56 intravesical infusion therapy 56 malignant mesothelioma Alfacell 56 oral picoplatin 56 http:/www.sangamo.com/ 56 mg q#h 56 lintuzumab SGN 56 EVIZON TM squalamine lactate 56 model bai xing 56 LentiVector technology 56 TSX VENTURE MKI 56 P#X# antagonist 56 estrogen receptor beta agonist 56 evaluating T DM1 56 hypoxia selective 56 randypeterson@dmreg.com 56 Inc. Nasdaq IMGN 56 RNAi Therapeutic 56 Genentech sanofi aventis 56 recombinant biopharmaceutical 56 IMiDs R 55 FOLFOX6 chemotherapy regimen 55 BiTE antibodies targeting 55 protein tyrosine phosphatase 1B 55 topical antifungal product 55 BiTE R 55 ALTROPANE R 55 vaccine GRNVAC1 55 imetelstat GRN#L 55 RONKONKOMA NY BUSINESS WIRE 55 nucleotide analog 55 LymphoStat B TM 55 Quinamed R 55 lexidronam injection 55 compound ITMN 55 gastrin analogue TT 55 targets Galectin receptors 55 systemically administered 55 lead Aganocide compound 55 PEG SN# 55 essential thrombocythemia ET 55 AIM OBP 55 cytomegalovirus immune globulin 55 MEK Inhibitor 55 Phase Ib II 55 dasatinib Sprycel ® 55 CCR5 mAb 55 Presents Preclinical Data 55 Aflibercept 55 markets Testim ® 55 therapeutic monoclonal antibody 55 oral prodrug 55 Prodarsan ® 55 adrenergic regulation 55 therapy Tovaxin 55 Imetelstat 55 Merck Serono Nycomed 55 Romidepsin 55 including eniluracil ADH 55 Genasense oblimersen sodium Injection 55 Nasdaq PARD 55 class anticancer quinolone 55 metaglidasen 55 cancer indications bafetinib 55 candidate REP# 55 include VALSTAR TM 55 Inc. NASDAQ GLGC 55 multicenter Phase II 55 MKC# MKC# PP 55 investigational protease inhibitor 55 Zemiva TM 55 nilotinib Tasigna ® 55 visit www.sciclone.com 55 CORLUX CORT # 55 highly selective inhibitor 55 GAITHERSBURG Md. BUSINESS WIRE 55 Georges Gemayel 55 next generation URAT1 55 pan BCR ABL 55 trastuzumab Herceptin R 55 hyperphenylalaninemia HPA due 55 anticoagulant reversing agent 55 modified nucleoside 55 FSC Carmanah Technologies 55 molecular imaging radiopharmaceutical 55 PET FROM 55 Deposition MOCVD Systems 55 Clin Orthop 55 Naglazyme R 55 http:/www.sangamo.com 55 ZFNs clinical trials 55 potently inhibited 55 Hsp# Inhibitor 54 markets COLAZAL 54 Personalized Immunotherapy 54 phase IIb study 54 class oral heparinoid 54 THR beta agonist 54 Inc. www.chemaphor.com uses 54 midstage clinical 54 candidate XP# 54 Ostabolin C TM 54 AAG KOS 54 whi.org.uk. 54 IMiDs ® 54 peers Durning 54 selective androgen receptor modulators 54 dlazarus@sfchronicle.com 54 defensin mimetic antibiotic 54 GRNVAC1 54 RAS MAPK pathway 54 Initiate Phase 54 SAR# [004] 54 TerraX Minerals Inc. 54 resorbable biomaterials 54 Pharmos pipeline 54 alvespimycin 54 ALN PCS 54 preclinical efficacy 54 optimal dosing regimens 54 alpha folate receptor 54 Cephalon GlaxoSmithKline 54 Fortical ® nasal calcitonin 54 transthyretin mediated amyloidosis ATTR 54 ALN TTR 54 Oracea TM 54 RNAi therapeutic targeting 54 Captisol ® 54 By JULIA REYNOLDS 54 anaplastic lymphoma kinase ALK 54 ARRY # 54 NASDAQ INGN 54 R#/MEM # 54 CORT # 54 gastro intestinal inflammation 54 APOPTONE 54 evaluating satraplatin 54 CYP#A# CYP#D# 54 monoclonal antibody conjugated 54 Phase III Pivotal 54 By KATHY ROUTLIFFE 54 apoptosis inducer 54 irinotecan doxorubicin oxaliplatin paclitaxel 54 molecular imaging radiopharmaceuticals 54 using ImmunoGen TAP 54 Cloretazine ® 54 Clinical Trials Update 54 generation radiolabeled antibody 54 apoptosis proteins 54 Vitaxin 54 oral proteasome inhibitor 54 NASDAQ REGN 54 Zenvia ™ 54 acid phosphatase PAP 54 evaluating picoplatin 54 Miraxion Amarin lead 54 By Parag Deulgaonkar 54 dimebon latrepirdine 54 CD4 monoclonal antibody 54 modified glutathione analog 54 candidate AQ4N 54 Asentar TM 54 developing Zerenex TM 54 oral ferric iron 54 VOGRIN THE GAZETTE 54 deCODE chemistry 54 joists beams 54 MGd 54 investigational humanized monoclonal antibody 54 PHX# 54 REVIVE Diabetes 54 candidate bevirimat PA 54 toenail onychomycosis 54 EGEN 54 HCV polymerase 54 cMET 54 Entereg R 54 forodesine 54 targeting refractory relapsing 54 Cerashield ™ 54 Iluvien ® 54 By Kari Petrie 54 mitogen activated ERK kinase 54 XL# inhibits 54 MT#/MEDI-# 54 GLOBE NEWSWIRE Nabi Biopharmaceuticals 54 peptidic compound 54 vinca alkaloid 54 HCV protease inhibitor 54 reversible inhibitor 54 photodynamic therapy dermatology 54 Vascular Disrupting Agent 54 androgen receptor modulator 54 Phase 2b Clinical Trial 53 MEK inhibitor 53 ® SMART SEED 53 commercializes therapeutic proteins 53 AEG# 53 Biopharmaceuticals AG 53 AKT inhibitor 53 www.holliseden.com 53 Satlynx GE 53 Kahalalide F 53 please visit www.middlebrookpharma.com 53 CTAP# Capsules 53 interferon gamma 1b 53 called maturation inhibitors 53 Ophena TM 53 erlotinib Tarceva ® 53 PDX pralatrexate 53 HepDirect prodrug 53 ATL# [002] 53 plant stanol ester 53 BY KATIE STRANG caitlin.strang 53 Nasdaq HNAB 53 pan histone deacetylase 53 2 methoxyestradiol 53 Pruvel ™ 53 Aurora kinase inhibitor 53 receptor tyrosine kinase inhibitor 53 prokinetic agent 53 oral Hsp# inhibitor 53 www.polymedix.com 53 Anat Cohen Dayag 53 TASKi2 53 catalytic antioxidant compounds 53 Valortim R 53 NS5b 53 cetuximab Erbitux R 53 CEQ# 53 ALN HPN 53 virus AAV 53 personalized dendritic cell 53 mertansine 53 autologous cell 53 TKM Ebola 53 small molecule defensin 53 lucinactant 53 Homspera TM 53 NYSE Amex LB 53 HIV maturation inhibition 53 Homspera ® 53 polysaccharide polymer 53 Bezielle 53 anti PlGF 53 TRIOLEX ™ 53 tiapamil 53 Naproxen sodium 53 ingots wafers 53 Lisofylline LSF 53 bevacizumab Avastin R 53 selective androgen receptor modulator 53 Valero Benicia #.# 53 cutaneous T 53 Constructive Occlusion ® 53 Protexia R 53 小时 53 selectin antagonist 53 taxane resistant 53 TEMSO 53 Corporation Nasdaq RGEN 53 TRAIL receptor antibodies 53 website www.swwc.com 53 Sodium Sulfate Sodium Chloride 53 • mkilen@dmreg.com • 53 triciribine phosphate monohydrate 53 sunitinib Sutent ® 53 http:/www.memorypharma.com 53 delta opioid receptor 53 Boreal Genomics 53 phase IIb clinical 53 Antibody Drug Conjugate 53 Pentad TM 53 Onalta 53 investigational HCV polymerase 53 日 星期五 #:# BJT 53 signal detection CTSD 53 huN# DM1 53 TRO# 53 TBC# 53 Phase Ib clinical 53 Elusys 53 SNS# T 53 e# DOI 53 proprietary BiTE ® 53 5 FU leucovorin 53 antisense inhibitors 53 IL# PE#QQR 53 include PLX IBD 53 Ozarelix 53 novel orally administered 53 liposomal formulation 53 GATTEX ® 53 Payable Date Dec 53 treat refractory angina 53 novel synthetic peptide 53 include BioNeutralizers 53 anti amnesic 53 recombinant subunit vaccine 53 molecular therapeutics immunotherapies 53 EnVivo Pharmaceuticals 52 Psychiatry Clin Neurosci 52 Panzem R 52 proprietary bioresorbable polymer 52 By LISA SINK 52 5 fluorouracil leucovorin 52 mda 7 52 products include BioNeutralizers 52 HGS# 52 PRNewswire FirstCall Perrigo 52 IIa trial 52 3 registrational trial 52 dihydrochloride Tablets 52 BY SARAH WOMER 52 • HapFry@coloradoan.com • 52 generation URAT1 inhibitor 52 HCV NS3 protease 52 tubulin inhibitor 52 Aganocide ® 52 Solazed ™ 52 ADI PEG 52 Rigel R# 52 Kambayashi Shizuo Kambayashi 52 SP Phonovation PO Box 52 activate SIRT1 52 Mike Elfland TELEGRAM 52 pharmacokinetic PK study 52 metastatic renal cell 52 TELINTRA 52 NASDAQ HNAB 52 Archexin 52 Survivin antagonist 52 CTA# Injection 52 lexidronam injection PROSTASCINT 52 Phase 2b Trial 52 compound PMX # 52 transthyretin TTR mediated amyloidosis 52 generation antisense compounds 52 TNFerade ™ 52 NASDAQ SNTA 52 Phase 2a clinical trials 52 Deep Reactive Ion Etch 52 FOX MTX 52 Sulonex TM 52 rALLy clinical trial 52 synthetic retinoid 52 novel peptide 52 Investigational Oral 52 GLOBE NEWSWIRE Pressure BioSciences 52 midstage trials 52 PRNewswire FirstCall BioLife Solutions 52 c Raf kinase 52 cathepsin K inhibitor 52 Fx #A 52 GTC Biotherapeutics develops 52 Polymerase Inhibitor 52 davunetide intranasal AL 52 phase III isavuconazole 52 isoform selective 52 Oral NKTR 52 Richard Duckett TELEGRAM 52 antibody MAb 52 Vaxfectin R adjuvant 52 Tekmira SNALP stable 52 Multaq tablets 52 proprietary PEGylation 52 HeartMate ® 52 CryoValve R 52 targeting CD# 52 Acute Myeloid Leukemia AML 52 REGN# 52 By TAYA FLORES 52 sapacitabine CYC# 52 Gen Probe NASDAQ GPRO 52 • rlengerich@news-press.com • 52 XL# XL# XL# XL# 52 Locked Nucleic Acid 52 IPL# 52 lipid nanoparticle 52 教育 展 52 phase Ib 52 clinical trials dacetuzumab SGN 52 IMiDs ® compound 52 histone deacetylase HDAC inhibitor 52 Ueno founded 52 fosbretabulin 52 Trofex ™ 52 dacetuzumab SGN 52 recurrent glioblastoma multiforme 52 日 星期六 #:# BJT 52 Phase III ADT 52 BY KEIKO MORRIS keiko.morris 52 PROSTASCINT R 52 omecamtiv mecarbil formerly 52 oats soy 52 FOLFOX chemotherapy 52 CRLX# 52 measurable tumor regressions 52 GRN# 52 Aurora kinase 52 By MEGHAN VAN 52 Topline Results 52 immunotoxin 52 resolvin 52 ALN TTR# 52 mGluR5 NAM 52 PRNewswire TorreyPines Therapeutics 52 China #,#-#,# citric 52 XmAb ® 52 secretory phospholipase A2 sPLA2 52 PSN# [002] 52 RNA interference tkRNAi 52 plasmid DNA pDNA 52 KL4 Surfactant 52 CEAG explosion proof 52 injectable polymer 52 HCV protease inhibitors 52 Prodrug TAP technology 52 Ostarine ™ 52 ACTCellerate 52 ongoing Phase 1b 51 Panzem NCD 51 MEK inhibitor RDEA# 51 selectively inhibits 51 initiate Phase 1b 51 MVA HPV IL2 51 generation Hsp# inhibitor 51 Dave Nordman TELEGRAM 51 MTP inhibitor 51 Junovan TM 51 nalbuphine ER 51 gefitinib Iressa 51 sodium Injection 51 development peramivir neuraminidase 51 ALN VSP 51 Trodusquemine 51 specialized polyolefin plastic 51 urogynecologic surgical procedures 51 product Abreva ® 51 Ann Rheum Dis 51 HCV RNA polymerase 51 catalytic antioxidants 51 OXi# 51 • krocha@visalia.gannett.com • 51 CYT# vascular disrupting 51 GATTEX ™ 51 clinical trials Archexin 51 Capesaris 51 integrin inhibitor 51 Tarvacin TM 51 JAK2 Inhibitor 51 clinical trials SGN 51 MVA BN R 51 • bljohnsen@stcloudtimes.com • 51 TOCOSOL Camptothecin 51 topical gel formulation 51 CharterX News 51 Phase IIb trials 51 PRNewswire FirstCall Halozyme Therapeutics 51 compound CMX# 51 Assure Controls 51 EM BNA 51 disheveled bedrooms 51 nucleotide polymerase inhibitor 51 cortisol synthesis 51 lymphoid malignancies 51 BY STEFANI GUERRERO 51 humanised antibody 51 Celliance 51 Trofex 51 perifosine KRX 51 Phase 1a clinical 51 Ceflatonin R 51 INCB# [001] 51 FARM CALVES No. 51 BY CARLA ROCCAPRIORE • 51 PLK1 SNALP 51 AQ4N 51 TSX VENTURE EIL 51 Affibody 51 XL# XL# 51 BY KEVIN DUGGAN 51 Fumed metal oxides 51 Kinase Inhibitor 51 JAK inhibitors 51 Tarmogen 51 By KEITH ROYSDON 51 SIRT1 activators 51 Petroleumworld welcomes your 51 OMP #R# 51 Lenocta 51 vivo preclinical 51 Memory MRAM 51 By Jane Bokun 51 PRNewswire FirstCall XTL Biopharmaceuticals 51 HemoGenix 51 vivo toxicology 51 metastatic castration resistant 51 seliciclib CYC# 51 Inc. NASDAQ TRGT 51 stable nucleic acid 51 product TNFerade TM 51 By Douglas Karlson 51 Hexvix ® 51 Dr. Aiping Young 51 garlic hazelnuts 51 HGS ETR1 51 NU# direct 51 BROOMFIELD Colo. Business Wire 51 Triapine R 51 Ektron.Cms.Controls.ContentBlock.Fill 51 PRNewswire FirstCall TorreyPines Therapeutics 51 Genasense ® oblimersen 51 multicenter Phase 51 QLT# 51 Phase 2a clinical 51 Poly ICLC 51 AKIP ™ 51 histone deacetylase inhibitor 51 GLOBE NEWSWIRE CombiMatrix 51 gamma secretase inhibitor 51 candidates bavituximab 51 please visit www.sucampo.com 51 TKM ApoB 51 hormone LHRH antagonist 51 Parkinson disease levodopa induced 51 castrate resistant prostate cancer 51 MATT PAIS • 51 Exherin 51 Canvaxin TM 51 Premier Developer Axiotron 51 docetaxel Taxotere R 51 Tezampanel 51 systemic lupus erythematosus lupus 51 Metastatic Melanoma 51 dyskinesia PD LID 51 phase IIa 51 Bei Infant Powder 51 Art's Way Vessels 51 听力 51 CPI Aero ® 51 Niris Imaging System 51 serious systemic Staphylococcal 51 PTH analogue 51 BY PAT BURSON 51 drug conjugate 51 bear grahams 51 Amigal TM 51 Aplidin R 51 ZFP Therapeutics 50 docetaxel Taxotere ® 50 investigational pan BCR 50 Aganocide R 50 Fc fusion protein 50 Trofex TM 50 BY BRETT WILKISON 50 pan HDAC inhibitor 50 XP# XP# 50 5 6A 6B 50 DiLA2 50 • mbrumble@gannett.com • 50 PRTX 50 virus HCV infection 50 GLOBE NEWSWIRE Momenta Pharmaceuticals 50 headed cabbage leeks 50 candidate ATHX 50 GLOBE NEWSWIRE Penwest Pharmaceuticals 50 d Feline dry 50 Nasdaq TRMM 50 HCD# [002] 50 acetylcholinesterase AChE 50 preclinical toxicology 50 Vicriviroc 50 1g fiber 50 pharmacogenetic test 50 nucleoside tide 50 • mcarmin@jconline.com • 50 anticancer compound 50 BY SARAH REYNOLDS 50 Count waxed carton 50 GLP toxicology studies 50 Curaxin 50 • dcastell@visalia.gannett.com • 50 SNALP technology 50 Ampio Pharmaceuticals Inc. 50 MORAb 50 RISE NEUTRAL FALL 50 candidate FAV 50 Phase Ib study 50 Sapacitabine 50 R vancomycin hydrochloride 50 ® Spectracide ® 50 SB# ONX 50 poly ADP ribose polymerase 50 http:/www.nansulate.com 50 elotuzumab 50 EZN 50 Exherin TM 50 Phase IIa trials 50 drug conjugate ADC 50 VitiGam 50 compound INCB# 50 nepalnews.com pb Jan 50 Quinamed 50 novel topoisomerase 50 #F AV 50 North Medford #.#a 50 JVRS 50 Scanning Probe Microscope 50 plus Copegus R 50 PEGPH# 50 Solorel TM 50 tivozanib AV 50 See www.usa.canon.com printspeed 50 XL# XL# XL# 50 BY RICHARD ROMERO 50 DNA RNA Medicines 50 By DOROTHY SCHNEIDER 50 By Jane Laskey 50 PRNewswire FirstCall PXRE 50 meal granulated peanuts 50 EBx ® 50 margarines crackers cookies 50 ELACYT 50 By CHARLES RUNNELLS 50 developing Zerenex ferric 50 Powerlink ® 50 PEGylated interferon 50 Hematide ™ 50 Aganocide 50 Pak HPP 50 ganetespib 50 HGS ETR2 50 ELND# AZD 50 Valortim ® 50 gastrointestinal disorders ATI 50 HTRF R 50 intranasal formulation 50 imatinib Gleevec ® 50 日 星期四 #:# BJT 50 beta 1a 50 AEGR 50 antisense drug 50 HIV RDEA# 50 topically applied SEPA 50 Guanilib 50 Phase Ia 50 Aztreonam lysine 50 MKC# 50 velafermin belinostat 50 PRNewswire FirstCall Senomyx 50 SAR# [002] 50 neuronal nicotinic receptor NNR 50 IND submission 50 Pennsauken NJ Henderson 50 Androxal TM 50 polymerase inhibitor 50 POWERSTACK tm MC# 50 Pink Sheets AXLE TJT 50 IMiDs 50 CHASKA Minn. BUSINESS WIRE 50 Azedra TM 50 BY DANNY CRANDALL 50 CRMD# 50 BY LUIS HERNANDEZ 50 OCPP materials 50 bafetinib demonstrated 50 DLP subsystems 50 AMITYVILLE NY BUSINESS WIRE 50 HCV polymerase inhibitors 50 Zemiva ™ 50 selective kinase inhibitor 50 skeletal sarcomere activators 50 Zybrestat 50 MET inhibitor 50 ANAVEX #-# [002] 50 mGluR5 negative 50 • tflores@jconline.com • 50 SPP# [002] 50 YONDELIS 49 HQK 49 coup overthrew Jacobo 49 selective inverse agonist 49 ABL inhibitor 49 epothilones 49 Cyclooxygenase Inhibiting Nitric Oxide 49 gram saturated 49 AVN# [001] 49 NORCROSS Ga. BUSINESS WIRE 49 multi kinase inhibitor 49 compound perifosine 49 TKM PLK1 49 cell lymphoma CTCL 49 administered intranasally 49 Fc engineered 49 INS# [001] 49 Marqibo TM 49 solithromycin 49 HIV integrase inhibitor 49 MIKE BUTLER 49 TACI Ig 49 Miscellaneous Markets Independently 49 thiazolides 49 volociximab 49 Actilon 49 By CLAUDIA MELƒNDEZ 49 HREO TREO ratio 49 MEDRAD INC. 49 Ng Jing Yng 49 protein kinase inhibitor 49 RiVax 49 Count cellophane sleeve returnable 49 dextromethorphan quinidine 49 orally inhaled migraine 49 Tumour Vascular Disrupting Agent 49 systemic RNAi therapeutic 49 generation FBPase inhibitor 49 entinostat 49 PsychoGenics 49 Alzhemed TM 49 PRT# 49 Sidney Siberian Husky 49 BY ANDY NELESEN 49 By Geoffrey Calver 49 hepatitis C polymerase inhibitor 49 gallium containing 49 PEGylated 49 novel L DOS# 49 Locteron ® 49 sophisticated computational modeling 49 Hillandale Farms recalled 49 INGN 49 BY PAT FERRIER 49 KSP inhibitor 49 Psychopharmacology Berl 49 PEGylated Fab fragment 49 Gillian Brunette 49 biodefense pathogens 49 PKC# 49 RUEHL chains 49 CHARLES WEBSTER • 49 Intermezzo ® zolpidem tartrate 49 Pharmos proprietary 49 plasma kallikrein inhibitor 49 6 farmworkers draining 49 String Ribbon ® 49 RGB # 49 Resin Systems Inc. 49 urocortin 2 49 • rmikulak@courier-journal.com • 49 SUVN 49 Bioral Amphotericin B. 49 Command SPAWAR San Diego 49 PICKETT Staff Writer 49 cGMP manufacture 49 RNA antagonists 49 #:#-# [005] 49 BY TONY WALTER 49 oral Azacitidine